Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06388174 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Idiopathic Generalized Epilepsy Syndromes

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine to Shen Chun-Hongv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Shen Chun-Hong
4 trials monitored
See all monitored trials
Epilepsy
769 trials monitored
See 48 trials at risk
The idiopathic generalized epilepsies (IGEs) have historically included the syndromes childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and epilepsy with generalized tonic-clonic seizures alone (GTCA). Recognition of the IGEs is important for clinical care, as it informs diagnosis, prevents unnecessary investigation, allows optimal selection of anti-seizure medications (ASMs), and provides prognostic guidance. According to the new ILAE definition in 2022, the study aims to describe the clinical features, electroencephalographic, imaging findings and long-term prognosis.
Trial Details
NCT Number NCT06388174
Lead Sponsor Shen Chun-Hong
Conditions
(from sponsor)		 Epilepsy, Epilepsy, Idiopathic Generalized
Related terms Epilepsy, Epilepsy, Idiopathic Generalized
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov